The evolving picture of SARS-CoV-2 and COVID-19 in children: critical knowledge gaps
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-03
Type
Journal Article
Author
Priscilla Idele
Author
David Anthony
Author
Danzhen You
Author
Chewe Luo
Author
Lynne Mofenson
URL
https://gh.bmj.com/content/5/9/e003454
Rights
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Volume
5
Issue
9
Pages
e003454
Publication
BMJ Global Health
ISSN
2059-7908
Date
16/09/2020
Extra
Publisher: BMJ Specialist Journals
Section: Commentary
PMID: 32938610
DOI
10.1136/bmjgh-2020-003454
Library Catalog
gh.bmj.com
Language
en
Abstract
The initial impression that paediatric infection is uncommon and generally mild has been replaced by a more nuanced understanding of infectious manifestations in children across countries and by income group, with recognition of a widening disease spectrum.
Critical knowledge gaps remain that have significant public policy and programme implications.
Insufficient age and race/ethnicity disaggregated data are hindering efforts to assess fully the prevalence of SARS-CoV-2 infection and COVID-19 in children and the role of children in transmission.
Potential biologic differences in susceptibility to infection and transmissibility between children and adults need to be explored.
Determination of mother-to-child SARS-CoV-2 transmission requires appropriate samples obtained with proper timing, lacking in most studies.
Predictors of disease progression and morbidity and mortality in children need to be determined, particularly as the pandemic moves to low-income and middle-income countries.
The full spectrum of SARS-CoV-2 infection in children remains to be defined, and surveillance for and investigation of the pathogenesis of postinfectious sequelae, such as multisystem inflammatory syndrome, are vital.
Short Title
The evolving picture of SARS-CoV-2 and COVID-19 in children